- Investing Ideas
- /
- German Healthcare Sector
German Healthcare Sector
UPDATED Apr 03, 2024
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
79 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
MRK | €157.60 | -1.6% | -9.6% | €68.5b | €180.75 | PE24.3x | E9.9% | 1.4% | Pharmaceuticals & Biotech | ||
SHL | €55.66 | -1.3% | 3.3% | €62.1b | €60.33 | PE40.9x | E19.5% | 1.7% | Healthcare | ||
BAYN | €28.77 | 1.2% | -51.7% | €28.3b | €37.60 | PB0.9x | E43.1% | 0.4% | Pharmaceuticals & Biotech | ||
FRE | €24.63 | -1.3% | -1.2% | €13.9b | €36.22 | PE39.3x | E22.8% | 0% | Healthcare | ||
FME | €34.74 | -2.4% | -12.5% | €10.2b | €38.95 | PE20.4x | E22.0% | 3.4% | Healthcare | ||
AFX | €111.50 | -6.6% | -10.5% | €10.0b | €105.47 | PE36x | E11.7% | 1.0% | Healthcare | ||
1SXP | €39.80 | -2.5% | n/a | €6.0b | €38.31 | PE37.9x | E15.7% | 0.4% | Pharmaceuticals & Biotech | ||
GXI | €106.10 | 2.3% | 15.1% | €3.7b | €132.22 | PE31.6x | E19.7% | 1.2% | Pharmaceuticals & Biotech | ||
MOR | €67.25 | 0.07% | 305.4% | €2.5b | €58.71 | PS10.6x | E51.0% | n/a | Pharmaceuticals & Biotech | ||
EVT | €14.08 | -2.1% | -28.3% | €2.5b | €23.00 | PS3x | E50.9% | n/a | Pharmaceuticals & Biotech | ||
SYAB | €10.76 | -1.2% | 12.3% | €2.4b | €12.57 | PE25.6x | E27.9% | 0% | Healthcare | ||
DMP | €31.70 | -7.2% | -21.7% | €1.7b | €57.90 | PE27.4x | E26.4% | 2.8% | Pharmaceuticals & Biotech | ||
COP | €28.04 | -3.0% | -40.3% | €1.5b | €48.45 | PE31.9x | E28.9% | 3.6% | Healthcare | ||
NXU | €56.30 | -1.1% | 7.9% | €972.0m | €67.00 | PE40.4x | E15.8% | 0.4% | Healthcare | ||
FYB | €45.60 | -1.6% | -29.8% | €805.3m | €103.00 | PS11.7x | E69.2% | n/a | Pharmaceuticals & Biotech | ||
RHK | €11.70 | 6.4% | -12.7% | €783.2m | n/a | PE20.2x | n/a | 1.3% | Healthcare | ||
EUZ | €37.46 | 0.6% | -13.6% | €780.2m | €60.00 | PE26x | E9.2% | 1.3% | Healthcare | ||
PHH2 | €211.00 | -0.5% | -6.6% | €749.4m | n/a | PE26.4x | n/a | 3.8% | Healthcare | ||
SBS | €37.00 | -12.7% | -40.9% | €449.8m | €44.83 | PE34.4x | E18.6% | 1.5% | Healthcare | ||
CHG | €24.00 | -0.8% | 81.8% | €396.0m | €24.00 | PS7x | E104.8% | n/a | Healthcare | ||
ILM1 | €15.40 | -3.3% | -24.0% | €366.6m | €34.60 | PE19.5x | E30.3% | n/a | Healthcare | ||
PSG | €22.00 | 0.9% | -24.1% | €264.0m | €37.00 | PE17.6x | E10.8% | 2.2% | Pharmaceuticals & Biotech | ||
M12 | €14.10 | 11.0% | 99.2% | €258.2m | €16.75 | PE40.6x | E29.4% | 0% | Healthcare | ||
PUS | €17.50 | 0% | -6.4% | €144.3m | n/a | PE20.1x | n/a | 5.0% | Healthcare |